GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nidan Laboratories and Healthcare Ltd (NSE:NIDAN) » Definitions » ROCE %

Nidan Laboratories and Healthcare (NSE:NIDAN) ROCE % : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nidan Laboratories and Healthcare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nidan Laboratories and Healthcare's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.


Nidan Laboratories and Healthcare ROCE % Historical Data

The historical data trend for Nidan Laboratories and Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nidan Laboratories and Healthcare ROCE % Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROCE %
Get a 7-Day Free Trial 9.96 18.28 13.47 9.29 -0.26

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Mar24
ROCE % Get a 7-Day Free Trial 29.37 7.69 10.06 6.98 -

Nidan Laboratories and Healthcare ROCE % Calculation

Nidan Laboratories and Healthcare's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=-1.88/( ( (0 - 0) + (825.508 - 113.198) )/ 1 )
=-1.88/( (0+712.31)/ 1 )
=-1.88/712.31
=-0.26 %

Nidan Laboratories and Healthcare's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Mar. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Mar. 2023 )(Q: Mar. 2024 )
=0/( ( (0 - 0) + (825.508 - 113.198) )/ 1 )
=0/( ( 0 + 712.31 )/ 1 )
=0/712.31
=0.00 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nidan Laboratories and Healthcare  (NSE:NIDAN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Nidan Laboratories and Healthcare ROCE % Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nidan Laboratories and Healthcare Business Description

Traded in Other Exchanges
N/A
Address
Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa, Behind Aarti Apartment, Virar West, Palagar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.

Nidan Laboratories and Healthcare Headlines

No Headlines